Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy
Article in Expert Review of Clinical Immunology (March 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Immune-related adverse events with severe pain and ureteral expansion as the main manifestations: a case report of tislelizumab-induced ureteritis/cystitis and review of the literature
Article in Frontiers in Immunology (October 2023)
Management and prediction of immune-related adverse events for PD1/PDL-1 immunotherapy in colorectal cancer
Article in Frontiers in Pharmacology (April 2023)